Effects of interferon-α, interferon-γ and cAMP on the transcriptional regulation of the serotonin transporter

European Journal of Pharmacology

Volumn 349, Issue 2-3, 1998, Pages 317-324

  Morikawa, Osamu ^a   Sakai, Norio ^a   Obara, Hidefumi ^b   Saito, Naoaki ^a  

^a KOBE UNIVERSITY   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT (5 hydroxytryptamine, serotonin) transporter; Depression; Interferon; mRNA; Transcription

Indexed keywords

ALPHA INTERFERON; BUCLADESINE; GAMMA INTERFERON; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LINE; CHORIOCARCINOMA; CONTROLLED STUDY; CULTURE MEDIUM; DNA TRANSFER; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; TRANSCRIPTION REGULATION;

ANIMALS; CARRIER PROTEINS; CHORIOCARCINOMA; CYCLIC AMP; GENE EXPRESSION; HELA CELLS; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MESENCEPHALON; MICE; MICE, INBRED BALB C; NERVE TISSUE PROTEINS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032557589     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00187-3     Document Type: Article

References (37)

1. Anderson D.J., Berkowitz R.S. Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA-choriocarcinoma cell line JAR. J. Immunol. 135:1985;2498-2501.
2. Anderson G.M., Horne W.C. Activators of protein kinase C decrease serotonin transport in human platelets. Biochim. Biophys. Acta. 1137:1992;331-337.
3. Baldessarini, R.J., 1980. Drugs and the treatment of psychiatric disorders. In: Gilman, A.G., Goodman, L.S., Gilmans, G. (Eds.), The Pharmacological Basis of Therapeutics. MacMillan, New York, pp. 391-447.
4. Bennett W.A., Lagoo D.S., Brackin M.N., Hale E., Cowan B.D. Cytokine expression by models of human trophoblast as assessed by a semiquantitative reverse transcription-polymerase chain reaction technique. Am. J. Reprod. Immunol. 36:1996;285-294.
5. Blakely R.D., Berson H.E., Fremeau R.J., Caron M.G., Peek M.M., Prince H.K., Bradley C.C. Cloning and expression of a functional serotonin transporter from rat brain. Nature. 354:1991;66-70.
6. Blakely R.D., De F.L., Hartzell H.C. Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol. 196:1994;263-281.
7. Bosin T.R. Oxidant stress stimulates active transport of serotonin by platelets. J. Pharmacol. Exp. Ther. 248:1989;67-72.
8. Carlsson A., Jonason J., Lindqvist M., Fuxe K. Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine. Brain Res. 12:1969;456-460.
9. Cool D.R., Leibach F.H., Bhalla V.K., Mahesh V.B., Ganapathy V. Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J. Biol. Chem. 266:1991;15750-15757.
10. Darnell J.J., Kerr I.M., Stark G.R. JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
11. Farber J.M. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor IV family of cytokines. Proc. Natl. Acad. Sci. USA. 87:1990;5238-5242.
12. Fulop V., Steller M.A., Berkowitz R.S., Anderson D.J. Interferon-gamma receptors on human gestational choriocarcinoma cell lines: quantitative and functional studies. Am. J. Obstet. Gynecol. 167:1992;524-530.
13. Gutterman J.U., Fine S., Quesada J. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Ann. Inter. Med. 26:1982;549-556.
14. Hampson J., McLaughlin P.J., Johnson P.M. Low-affinity receptors for tumour necrosis factor-alpha, interferon-gamma and granulocyte-macrophage colony-stimulating factor are expressed on human placental syncytiotrophoblast. Immunology. 79:1993;485-490.
15. Hoffman B.J., Mezey E., Brownstein M.J. Cloning of a serotonin transporter affected by antidepressants. Science. 254:1991;579-580.
16. Jayanthi L.D., Ramamoorthy S., Mahesh V.B., Leibach F.H., Ganapathy V. Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells. J. Biol. Chem. 269:1994;14424-14429.
17. Kekuda R., Torres-Zamorano V., Leibach F.H., Ganapathy V. Human serotonin transporter: regulation by the neuroprotective agent aurintricarboxylic acid and by epidermal growth factor. J. Neurochem. 68:1997;1443-1450.
18. Kuhar M.J., Roth R.H., Aghajanian G.K. Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J. Pharmacol. Exp. Ther. 181:1972;36-45.
19. Launay J.M., Bondoux D., Oset G.M., Emami S., Mutel V., Haimart M., Gespach C. Increase of human platelet serotonin uptake by atypical histamine receptors. Am. J. Physiol. 266:1994;R526-536.
20. Lesch, K.P., Bengel, D., 1995. Neurotransmitter reuptake mechanisms: targets for drugs to study and treat psychiatric, neurological and neurodegenerative disorders. CNS Drugs, pp. 302-322.
21. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
22. Levenson J.L., Fallon H.J. Fluoxetine treatment of depression caused by interferon-alpha. Am. J. Gastroenterol. 88:1993;760-761.
23. Miller K.J., Hoffman B.J. Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. J. Biol. Chem. 269:1994;27351-27356.
24. Myers C.L., Lazo J.S., Pitt B.R. Translocation of protein kinase C is associated with inhibition of 5-HT uptake by cultured endothelial cells. Am. J. Physiol. 257:1989;L253-258.
25. Nakashita M., Sasaki K., Sakai N., Saito N. Effects of tricyclic and tetracyclic antidepressants on the three subtypes of GABA transporter. Neurosci. Res. 29:1997;87-91.
26. Nishio H., Nezasa K., Nakata Y. Role of calcium ion in platelet serotonin uptake regulation. Eur. J. Pharmacol. 288:1995;149-155.
27. Ogilvie A.D., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwim G.M., Smith C.A. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 347:1996;731-733.
28. Osawa I., Saito N., Koga T., Tanaka C. Phorbol ester-induced inhibition of GABA uptake by synaptosomes and by Xenopus oocytes expressing GABA transporter (GAT1). Neurosci. Res. 19:1994;287-293.
29. Ouellet S., Muller E., Rola P.M. IFN-gamma up-regulates platelet-activating factor receptor gene expression in human monocytes. J. Immunol. 152:1994;5092-5099.
30. Pestka S., Langer J.A., Zoon K.C., Samuel C.E. Interferons and their actions. Annu. Rev. Biochem. 56:1987;727-777.
31. Ramamoorthy S., Cool D.R., Mahesh V.B., Leibach F.H., Melikian H.E., Blakely R.D., Ganapathy V. Regulation of the human serotonin transporter: cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J. Biol. Chem. 268:1993;21626-21631.
32. Ramamoorthy J.D., Ramamoorthy S., Papapetropoulos A., Catravas J.D., Leibach F.H., Ganapathy V. Cyclic AMP independent up regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. J. Biol. Chem. 270:1995;17189-17195.
33. Ramamoorthy S., Ramamoorthy J.D., Prasad P.D., Bhat G.K., Mahesh V.B., Leibach F.H., Ganapathy V. Regulation of the human serotonin transporter by interleukin 1 beta. Biochem. Biophys. Res. Commun. 216:1995;560-567.
34. Renault P.F., Hoofnagle J.H., Park Y., Mullen K.D., Peters M., Jones D.B., Rustgi V., Jones E.A. Psychiatric complications of long-term interferon alpha therapy. Arch. Intern. Med. 147:1987;1577-1580.
35. Sekiya S., Kuwata T., Ishige H., Tomita Y., Takamizawa H. Effects of human interferons on human choriocarcinoma cells in vitro and in vivo. Gynecol. Oncol. 25:1986;115-124.
36. Sen G.C., Ransohoff R.M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:1993;57-102.
37. Stanley M., Virgilio J., Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science. 216:1982;1337-1339.